Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Newly Discovered Molecule Could Deliver… >
Newly Discovered Molecule Could Deliver Drugs to Treat Diseases

Published: September 24, 2012.
By Kansas State University
http://www.k-state.edu

MANHATTAN, Kan. -- Kansas State University researchers have discovered a molecule that may be capable of delivering drugs inside the body to treat diseases.

For the first time, researchers have designed and created a membrane-bounded vesicle formed entirely of peptides -- molecules made up of amino acids, the building blocks of protein. The membrane could serve as a new drug delivery system to safely treat cancer and neurodegenerative diseases.

A study led by John Tomich, professor of biochemistry at Kansas State University, has been published in the journal PLOS ONE in September, and a patent for the discovery is pending.

The peptides are a set of self-assembling branched molecules made up of naturally occurring amino acids. The chemical properties of a peptide create a vesicle that Tomich describes as a bubble: It's made up of a thin membrane and is hollow inside. Created in a water solution, the bubble is filled with water rather than air.

The peptides -- or bubbles -- can be made in a solution containing a drug or other molecule that becomes encapsulated as the peptide assembles, yielding a trapped compound, much like a gelatin capsule holds over-the-counter oral remedies. The peptide vesicles could be delivered to appropriate cells in the body to treat diseases and minimize potential side effects.

"We see this as a new way to deliver any kind of molecule to cells," Tomich said. "We know that in certain diseases subpopulations of cells have gone awry, and we'd like to be able to specifically target them instead of attacking every cell, including healthy ones."

The finding could improve gene therapy, which has the potential to cure diseases by replacing diseased cells with healthy ones. Gene therapy is being tested in clinical trials, but the biggest challenge is how best to deliver the genes.

Methods include cells with a virus being injected into the body, and liposomes -- fatty compounds -- carrying the genes. However, these methods may present some problems.

When a virus is used, the body's immune system can attack the virus or cause a tumor. Lipid-based systems may cause inflammation and may not properly bind to cells.

The peptides created by Kansas State University researchers have advantages over their lipid counterparts. The peptides have improved stability and durability, are easier and quicker to create, and they could be delivered to a specific area in the body.

The peptides can be designed to have the ability to target cells, tissues, tumors or organs, and to encapsulate chemical reagents, antibodies, toxins and inhibitors, Tomich said.

"We don't even begin to know all of the potential applications for this discovery," he said. "We envision that many products could be packaged and delivered using these peptides."


Show Reference »


Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


 
All comments are reviewed before being posted. We cannot accept messages that refer a product, or web site.If you are looking for a response to a question please use our another feedback page.
Related »

Molecules 
6/15/10 
Inflammatory Diseases: Scientists Identify Antiviral Defense
By University of Montreal
Montreal, June 15, 2010 – Canadian researchers have discovered a new way the body combats respiratory viral infections. In the prestigious journal PLoS Pathogens, scientists from the University of …
Viral 
7/1/13 
Placental Cells May Prevent Viruses from Passing from Mother to Baby, Says Pitt/MWRI Team
By University of Pittsburgh Schools of the Health Sciences
PITTSBURGH, July 1, 2013 – Cells of the placenta may have a unique ability to prevent viruses from crossing from an expectant mother to her growing baby and can …
Kaposi 
1/13/14 
★ 
Viral MicroRNAs Responsible for Causing AIDS-related Cancer, New USC Study Shows
By University of Southern California - Health Sciences
LOS ANGELES - For the first time, scientists and engineers have identified a critical cancer-causing component in the virus that causes Kaposi's sarcoma, the most common cancer among HIV-infected …
Receptor 
9/27/13 
Baculovirus-recognizing Human Cell Receptor Identified for the First Time
By University of Eastern Finland
The receptor used by baculovirus to enter and interact with human cells has been identified. This syndecan-1 receptor was identified for the first time in a recent collaborative study …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile  |  Japanese Edition
All contents are copyright of their owners except U.S. Government works. U.S. Government works are assumed to be in the public domain unless otherwise noted. Everything else copyright ScienceNewsline.